Abstract
This review presents the clinical pharmacokinetics of imatinib mesylate. Aspects regarding absorption, tissue distribution, elimination and kinetic interactions are also discussed.
Footnotes
- Received November 3, 2004.
- Accepted December 17, 2004.
- Copyright © 2005 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved